The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Construction
  • Automotive
  • Technology
  • Music
  • Arts

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fate Therapeutics, Inc. (FATE) Investors
The PennZone/10217761

Trending...
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Fate Therapeutics, Inc. ("Fate" or the "Company") (NASDAQ: FATE) securities between April 2, 2020 and January 5, 2023, inclusive (the "Class Period"). Fate investors have until March 22, 2023 to file a lead plaintiff motion.

Investors suffering losses on their Fate investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On January 5, 2023, after the market closed, Fate announced that it had terminated its collaboration and option agreement for cell-based cancer immunotherapies with Johnson & Johnson's Janssen, and that all collaboration activities would be wound down in the first quarter of 2023.

More on The PennZone
  • COHN Named Colorado State-Approved Vendor for Advertising & Marketing Services
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think
  • RTC Communications Preliminarily Awarded $3.1 Million Federal BEAD Grant to Expand Fiber Broadband in Southern Indiana
  • She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
  • Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand

On this news, Fate's stock price fell $6.76, or 61.5%, to close at $4.24 per share on January 6, 2023, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors; (2) accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources; (3) as a result, Fate had overstated the impact of the Janssen Collaboration Agreement's on Fate's long-term clinical and commercial profitability; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased Fate securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

More on The PennZone
  • IDCXS Exchange Founder Travels to Angola for Strategic Cooperation Talks
  • 2026 NBA Mock Draft: New Wave of Franchise Talent Emerges in Early Lottery Projections
  • Bad Bunny Leads 2026 Grammys Album of the Year Odds, Lady Gaga Emerges as Top Challenger
  • Metro Detroit teen Lola Winters turns viral TikTok fame into a sold-out clothing brand
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Bent Danholm Releases New Video Breaking Down the Rising Debate Over 50-Year Mortgages
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
  • Ali Alijanian, DDS Featured in The Profitable Dentist Magazine
  • "Meet the Eatmons" Offer Financial Advice ahead of the Holidays
  • CCHR: Study Finds Involuntary Commitment Fails to Prevent Suicide, Raises Risk
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
  • Historic Announcement for the Global Car Rental Industry
  • Siembra Brings 18 Latinx Artists Together in Brooklyn Exhibition
  • Gramercy Tech Launches StoryStream
  • Entrigue Magazine LLC Announces Strategic Media Partnership with Reewind Network LLC
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Outreaching.io Appoints Rameez Ghayas Usmani as CEO, Recognized as Best HARO Link Building Expert in the United States
  • Winzele: A Trusted Isolation Transformer Manufacturer
  • Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
  • ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions

Popular on PennZone

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 455
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
  • Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field

Similar on PennZone

  • Inframark Expands Its Specialized Automation and Intelligence Capabilities, Adds Dmytryka Jacobs Engineers
  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • 2026 NBA Mock Draft: New Wave of Franchise Talent Emerges in Early Lottery Projections
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
  • Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta
  • Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens
  • Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • "Meet the Eatmons" Offer Financial Advice ahead of the Holidays
  • Slotozilla's Q3 2025: SBC Lisbon Outcomes and Partnership Expansion
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us